Lenograstim is a recombinant human granulocyte-colony stimulating factor (G-CSF) used to reduce the risk of life-threatening infection in patients with neutropenia, particularly after cytotoxic chemotherapy.
Letermovir is an antiviral CMV DNA terminase complex inhibitor which is prescribed for prevention of the development of cytomegalovirus (CMV) infection in adult patients who underwent stem cell transplant or who test positive for the CMV antigens but do not suffer from the disease.
Levocarnitine is prescribed for the prevention and treatment of carnitine deficiency in: Primary carnitine deficiency, where the cause of the deficiency is not known Secondary carnitine deficiency, due to inborn errors of metabolism like medium chain fatty acylCoA dehydrogenase deficiency.
Lofexidine is a centrally acting α-2 adrenergic receptor agonist, prescribed for reducing the severity of opioid withdrawal symptoms in adults, with the focus to facilitate the abrupt discontinuation of opioids or following the completion of opioid therapy.
Lusutrombopag is used to treat thrombocytopenia, a condition of abnormally low platelet counts in adult patients with severe liver dysfunction who are scheduled to undergo a medical or dental procedure.
Lutetium Lu 177 dotatate is a somatostatin analog radioactive drug or a radiopharmaceutical which is used for treating adult patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer